Healthcare AI Companies

Find healthcare AI companies by the work they do. Compare products and ownership, then explore company news and evidence before building your shortlist.

Directory Snapshot

Research the Company From More Than One Angle

Use nine market categories to narrow the field, then open a company profile for its ownership, stock name or public parent, first-hand developments, careers, qualification signals, evidence, and regulatory record.

Open the Healthcare AI Company Market Map

71
Company profiles
12
Market categories
17
Public-market links

Company News and Research Updates

What Changed, From the Source

See all company developments

... Commure

Commure gets Epic Toolbox status for autonomous coding, and reports an 83 percent cut in charge entry time at Ob Hospitalist Group

Commure said on 20 October 2026 that Commure Autonomous Coding had achieved Epic Toolbox designation for fully autonomous coding. The announcement describes the Toolbox designation as marking vendors that follow Epic's recommended Blueprint and integration practices, which it says streamlines integration and security review and lets coders check codes inside their existing Epic system. Commure says the product recommends ICD-10, CPT and E&M codes and modifiers with a written rationale, covering the step from a clinician's note through claim creation. The announcement reports that at Ob Hospitalist Group, described as the nation's largest OB/GYN provider group, clinicians cut charge entry time by 83 percent within three months and the software coded more than 85 percent of all charges. Tanay Tandon, Commure's chief executive, is quoted saying healthcare spends more than 250 billion dollars a year on administrative work that produces no clinical value.

Why it matters: Toolbox designation is an integration and process credential, not a measure of coding accuracy. It matters because it removes a real obstacle: coders reviewing AI output in a second application is where a lot of autonomous coding pilots quietly die. The customer figures are the part worth pressing on. An 83 percent cut in charge entry time is a measure of clinician effort, and 85 percent of charges coded is a measure of how much work the software took on, but neither one tells you whether the codes were right or whether denials went up or down. A revenue cycle leader should ask for the accuracy and denial numbers beside these two before treating the result as a win, and should note that an obstetrics hospitalist group has a narrower range of cases than a general hospital.

... Philips

Philips says its SmartSpeed Precise MRI software has reached 1,000 installations

Philips said on 14 October 2026 that it had reached 1,000 global installations of SmartSpeed Precise, its AI-based MRI image reconstruction software. The company says the software is used in at least 95 percent of compatible clinical scanning on the systems where it is installed. Its stated performance claims are that SmartSpeed Precise delivers images up to 80 percent sharper and lets scans be completed up to three times faster compared with Philips SENSE imaging, that it can save an average of 215 hours of scanning time per system per year, and that this represents capacity for roughly 624 additional MRI examinations per system each year, or about 215,000 hours and more than 624,000 additional examinations across all 1,000 systems. Ioannis Panagiotelis, business leader for MRI at Philips, is quoted saying faster is only meaningful when it comes with the image quality clinicians need.

Why it matters: The adoption figure is the useful part of this announcement. Plenty of imaging AI gets bought, installed and then left switched off because it slows the technologist down or the radiologists do not trust the output, so a vendor claiming the software runs on nearly every eligible scan is making a claim it can be checked on. The time figures need more care. The 215 hours and the 624 extra examinations are Philips arithmetic built on its own comparison against its older SENSE method, not an independent measurement, and extra scanner capacity only turns into extra examinations if a department also has the staff and the referrals to fill it. Nothing here is a clinical claim, and faster scans with sharper pictures do not by themselves mean a better diagnosis.

... Abridge

Abridge turns its note-taking tool into an assistant that answers questions about the patient

Abridge said on 13 October 2026 that Abridge Assistant, which works inside the records system and is reached by chat or by voice, is now available to every clinician at every health system it serves, following a release in September. The company says the assistant pulls relevant details out of the chart with the sources cited, surfaces clinical guidance, drafts documents such as referrals and handoffs for a clinician to review, personalises notes using the patient's context, and can fold a health system's own clinical pathways into its answers. Abridge says it shows its work step by step rather than returning an answer alone, and that more than 300 enterprise health systems use its products. Abridge says it works with Epic and other records systems. Matt Troup, a physician assistant and Abridge clinical strategy principal, is quoted saying the assistant knows his patient and shows the work.

Why it matters: Drafting a note from a conversation that already happened is a contained job. Answering a question about a patient, and offering guidance, is not, because a wrong answer can reach a decision. Two things in the announcement are the ones to hold onto. The citations and the visible reasoning steps are the part an informatics team can actually audit, so ask whether a clinician can click through to the chart entry behind every claim. And the clinical pathway feature means the answers will reflect whichever version of the pathway was loaded, which makes pathway governance a safety job rather than a content job. Nothing here is a clinical claim, and Abridge describes the drafts as material for a clinician to review, not to send.

... DeepScribe

Comprehensive Cancer Centers of Nevada puts DeepScribe's ambient AI into care at 13 locations

DeepScribe said on 13 October 2026 that Comprehensive Cancer Centers of Nevada had made its ambient AI part of care across 13 treatment locations in Southern Nevada, covering 59 oncology clinicians. The announcement reports over 90 percent clinician adoption, says 80 percent of all patient encounters are documented using the platform, and says 8 in 10 clinicians were using its SmartPrep pre-visit feature by the second month. It says the rollout runs on the practice's iKnowMed records system, and describes the practice as participating in more than 150 clinical trials a year and having contributed to the development of more than 100 therapies approved by the FDA. Rupesh Parikh, the practice president, is quoted saying DeepScribe has given its physicians room back. Matthew Ko, DeepScribe's chief executive and founder, is quoted saying the speed of adoption signals the company is helping solve the right problems. The announcement gives no time-saved figure.

Why it matters: This is the first brief this site holds for DeepScribe, and the useful thing about it is what it measures. Ambient documentation tools are usually sold on minutes saved, a number that is hard to verify and easy to inflate. Adoption and share of encounters documented are harder to fake, because a clinician who dislikes the tool simply stops opening it. Treat the setting as the main caveat: oncology visits in a single practice follow familiar patterns, with the same clinicians and the same record system, which is a much easier environment than a general hospital with rotating staff. Note also that the location and clinician counts come from the vendor, and the practice's own pages describe 12 treatment centres and over 600 medical professionals, so the two organisations are counting different things.

... EliseAI

EliseAI and Nextech plan voice AI for specialty practices in 2027

EliseAI announced preferred-partner status for inbound and outbound voice AI in Nextech practices. The initial focus is ophthalmology and dermatology, with joint availability planned for the start of 2027.

Why it matters: Connecting a phone agent to the practice schedule could reduce repeated work. A partnership announcement still leaves a practical question: when will a practice be able to use the promised integration?

Ambient Clinical Documentation

Tools that listen to the patient encounter and draft the clinical note automatically, aimed at the documentation burden behind physician burnout.

  • Abridge

    Clinical AI platform for visit documentation with products for clinicians and nursing teams. Its September release adds inpatient documentation cues and specialty support.

    No direct public shares are available.

    Company research Official site

  • Microsoft Nuance (DAX / Dragon Copilot)

    The incumbent in clinical speech, now folded into Microsoft. Combines long-standing medical dictation with ambient note generation, and carries the deepest existing footprint in hospital dictation workflows of anyone in this group.

    Public parent: Microsoft, Nasdaq: MSFT.

    Company research Official site

  • Ambience Healthcare

    Ambient documentation aimed at specialty-specific note structures and coding support, rather than treating every encounter as the same generic transcript.

    No direct public shares are available.

    Company research Official site

  • Suki

    Voice-first clinical assistant covering ambient notes plus dictation and command-driven EHR actions, positioned around clinician-controlled input rather than fully passive capture.

    No direct public shares are available.

    Company research Official site

  • Nabla

    Ambient assistant with a strong ambulatory and international footprint, generating notes from the encounter and pushing them into the record.

    No direct public shares are available.

    Company research Official site

  • DeepScribe

    Ambient documentation focused on customizable note formatting per clinician, so the output matches how a specific physician already writes.

    No direct public shares are available.

    Company research Official site

  • Heidi

    AI clinical assistant for visit notes and follow-up work. Heidi II extends the product into chart preparation and referral tasks with clinician review controls.

    No current public listing was verified.

    Company research Official site

What to verify: What happens to the audio and transcript after the note is drafted: retention period, whether it feeds further model training, and whether compliance has actually reviewed the processing arrangement.

Medical Imaging and Diagnostic AI

Systems that analyze radiology, pathology, and cardiology images and flag findings for clinician review.

  • Aidoc

    Radiology triage AI that flags suspected acute findings such as intracranial hemorrhage and pulmonary embolism to move them up the read list. One of the larger FDA-cleared portfolios in imaging triage.

    No direct public shares are available.

    Company research Official site

  • Viz.ai

    Care coordination built on imaging AI: detects suspected large vessel occlusion stroke and alerts the intervention team directly, compressing time-to-treatment rather than only flagging the scan.

    No direct public shares are available.

    Company research Official site

  • PathAI

    AI for digital pathology, applied to both diagnostic support and pharmaceutical research workflows where consistent slide interpretation is the bottleneck.

    No direct public shares are available.

    Company research Official site

  • Lunit

    Imaging AI concentrated in mammography screening and chest radiography, with a significant deployment base in national screening programs outside the United States.

    Direct listing: Korea Exchange KOSDAQ: 328130.

    Company research Official site

  • Harrison.ai Radiology

    Radiology AI formerly marketed as Annalise.ai, now operating under the Harrison.ai Radiology name across chest X-ray and CT decision support.

    No direct public shares are available.

    Company research Official site

  • RapidAI

    Neurovascular imaging analysis for stroke and aneurysm workflows, widely embedded in comprehensive stroke center protocols.

    No direct public shares are available.

    Company research Official site

  • GE HealthCare

    Public healthcare technology company spanning imaging, ultrasound, monitoring, diagnostics, and AI-enabled software used across hospital workflows.

    Direct listing: Nasdaq: GEHC.

    Company research Official site

  • Siemens Healthineers

    Public medical technology company with imaging, diagnostics, cancer-care, and digital businesses that use AI across equipment and clinical workflow.

    Direct listing: Frankfurt and Xetra: SHL.

    Company research Official site

  • Philips

    Public health technology company using AI across diagnostic imaging, ultrasound, monitoring, informatics, and image-guided therapy.

    Direct listings: NYSE: PHG and Euronext Amsterdam: PHIA.

    Company research Official site

  • DeepHealth

    RadNet subsidiary combining radiology informatics, workflow, and clinical AI across breast, chest, neuro, prostate, thyroid, and other imaging work.

    Public parent: RadNet, Nasdaq: RDNT.

    Company research Official site

  • Avicenna.AI

    CT software that flags urgent and incidental findings, sold as the CINA product family. It covers brain bleeds, large vessel occlusion, pulmonary embolism, aortic dissection and spine fractures, and is used by radiology departments and teleradiology providers.

    No current public listing was verified.

    Company research Official site

  • ScreenPoint Medical

    Transpara reads 2D and 3D mammograms to help a radiologist find breast cancer, rate breast density, and compare a scan against a woman's earlier images. Screening programs are its main buyer.

    No current public listing was verified.

    Company research Official site

  • Brainomix

    Brainomix 360 reads brain scans to support decisions in acute stroke care, and e-Lung measures features on lung CT scans. Hospitals use the stroke product in the treatment window, and drug companies use the lung product as a trial measurement.

    No current public listing was verified.

    Company research Official site

  • Qure.ai

    Qure.ai reads chest X-rays, CT scans and other images to flag findings and move urgent cases up the list. The company says it holds 26 FDA-cleared indications across nine products, and it sells to hospitals, screening programs and public health projects in the United States, India and Africa.

    No current public listing was verified.

    Company research Official site

  • Therapixel

    MammoScreen reads a mammogram and marks the places a radiologist should look again for breast cancer. Therapixel is a French software company, and breast screening programs and radiology groups are its buyers.

    No current public listing was verified.

    Company research Official site

  • Koios Medical

    Koios DS reads ultrasound images of the breast and the thyroid and gives the radiologist a second opinion on whether a lump looks suspicious. The company says the software is FDA cleared, CE marked and a billable procedure.

    No current public listing was verified.

    Company research Official site

  • JLK

    JLK sells MEDIHUB, a family of AI tools that read brain scans and other medical images, with stroke care as the main focus. The company is based in South Korea and its shares trade on the KOSDAQ market.

    Direct listing: KOSDAQ: 322510.

    Company research Official site

  • AZmed

    Rayvolve reads X-rays and marks fractures and chest findings for the radiologist. AZmed is based in Paris and sells to hospital radiology departments in Europe and the United States, and the company says Rayvolve now covers eight FDA-cleared findings.

    No current public listing was verified.

    Company research Official site

  • BrightHeart

    The B-Right platform watches a prenatal ultrasound as it happens and helps the sonographer check that the baby's heart views are complete and read correctly. BrightHeart is based in Paris, and its two products, B-Right Views and B-Right Screen, are both FDA cleared and CE marked.

    No current public listing was verified.

    Company research Official site

  • Sonio

    Sonio follows a fetal ultrasound as it happens, checks that the required views were actually captured, flags findings that look abnormal, and writes the report. The company says it has five FDA clearances in under three years, and Samsung now owns it.

    Public parent: Samsung. The exact listed Samsung entity holding the shares was not verified, so no ticker is recorded here.

    Company research Official site

  • Odin Vision

    CADDIE watches a colonoscopy as it happens and points out polyps the doctor should look at again, and CADU does the same job for a gastroscopy. Odin Vision is a London company, and Olympus bought it in 2023, so the software now sits beside Olympus endoscopy equipment.

    Public parent: Olympus Corporation, Tokyo Stock Exchange.

    Company research Official site

  • Hologic

    Hologic makes breast imaging, surgical and laboratory products for women's health, and its Genius AI Detection software reads 3D mammograms and marks the spots a radiologist should check for cancer. Blackstone and TPG took the company private in April 2026, so its shares no longer trade.

    No current public listing. Hologic's shares were delisted from Nasdaq when the take-private closed on 7 April 2026.

    Company research Official site

  • Digital Diagnostics

    LumineticsCore looks at a photo of the back of the eye and decides on its own whether a person with diabetes has diabetic retinopathy, without an eye doctor reading the image. Primary care clinics are the main buyer, and the company says the result comes back in about 30 seconds.

    No current public listing was verified.

    Company research Official site

  • Nanox.AI

    Reads routine CT scans a patient already had and flags signs of heart, liver, and bone conditions that were not the reason for the scan, so they can be caught earlier. Formerly Zebra Medical Vision.

    Public parent: Nano-X Imaging, Nasdaq: NNOX.

    Company research Official site

What to verify: Which specific FDA clearance covers which specific finding on which specific modality. A clearance for one use case is not validation for everything the marketing page implies.

Clinical Decision Support and Predictive Risk

Models that predict deterioration, sepsis onset, or readmission risk and surface it to clinicians as an alert or recommendation.

  • Epic

    Not a standalone AI vendor, but the place most predictive models actually run. Epic ships native predictive models and an increasing amount of generative capability inside the record, which means the EHR is often the real competitor to any point solution in this group.

    No direct public shares are available.

    Company research Official site

  • Bayesian Health

    Real-time clinical deterioration and sepsis detection built around reducing alert fatigue, with published work on prospective validation rather than retrospective accuracy alone.

    No direct public shares are available.

    Company research Official site

  • Navina

    AI assistant that brings patient history into chart review and value-based care. It supports diagnosis documentation and care-gap work using information from existing records.

    No current public listing was verified.

    Company research Official site

  • Regard

    AI clinical support that reviews patient records for possible missed diagnoses and drafts documentation for clinician review. Its products also support hospital revenue work and risk adjustment.

    No current public listing was verified.

    Company research Official site

  • Anumana

    ECG-AI reads a standard 12-lead ECG and flags signs of heart disease for a clinician to review. Anumana holds FDA clearances covering low ejection fraction, pulmonary hypertension and cardiac amyloidosis, so a hospital can look for those conditions in a test it already runs every day.

    No current public listing was verified.

    Company research Official site

What to verify: What population the model was validated on. A sepsis model trained on one health system can behave very differently on a different demographic and case mix.

Care Operations and Hospital Workflow AI

Systems that coordinate beds, surgery, discharge, care gaps, and the work between clinical teams so hospitals can use scarce capacity more effectively.

  • Qventus

    Hospital operations platform using AI and workflow automation across surgery, inpatient capacity, care coordination, and care-gap work.

    No direct public shares are available.

    Company research Official site

  • Trase

    Trase builds AI agents that do back office jobs inside regulated organisations, and in healthcare that means work like sorting incoming faxes, patient intake, prior authorisation, insurance checks and nurse rostering. Duke Health is the named healthcare customer on its own site. Its products are Trase Origin, Trase Arena and Trase Leagues.

    No current public listing was verified.

    Company research Official site

What to verify: Which tasks are truly completed by the system, which still depend on staff follow-up, and what measurable capacity or care result changes after exceptions are counted?

Enterprise Healthcare AI and Data Platforms

Platforms that connect healthcare data, AI applications, agents, analytics, and workflow services across a health system or payer.

  • Innovaccer

    Healthcare data and AI platform spanning provider, payer, population health, patient access, revenue, analytics, and agent-based workflow products.

    No direct public shares are available.

    Company research Official site

  • Commure

    Commure sells a bundle of AI tools that cover a patient visit end to end: ambient notes, dictation, call centre agents, referral intake and revenue cycle work. The company says it works with more than 130 health systems across more than 3,000 sites of care.

    No current public listing was verified.

    Company research Official site

What to verify: Does the platform reduce the number of disconnected tools and data copies, or does it become one more layer the organization has to integrate, govern, and pay for?

Patient Access and Engagement

AI applied to intake, scheduling, triage, and how patients find and reach a health system in the first place.

  • Hippocratic AI

    Patient-facing voice AI agents for non-diagnostic outreach, chronic-care support, follow-up, education, screening, and health-system contact work.

    No direct public shares are available.

    Company research Official site

  • Notable Health

    Automation across intake, registration, scheduling, and referral workflows, targeting the administrative friction patients hit before they ever see a clinician.

    No direct public shares are available.

    Company research Official site

  • Hyro

    Conversational AI for health system call and web traffic, handling scheduling, prescription refills, and routing without sending every caller to a human queue.

    No direct public shares are available.

    Company research Official site

  • Luma Health

    Patient engagement across scheduling, reminders, waitlist backfill, and referral management, aimed at no-show rates and unused capacity.

    No direct public shares are available.

    Company research Official site

  • Artera

    Patient communication layer that unifies messaging across service lines, with AI applied to triage and translation of inbound patient messages.

    No direct public shares are available.

    Company research Official site

  • EliseAI

    AI patient communication for scheduling and follow-up. The healthcare business handles calls and messages, while the wider company also serves housing customers.

    No current public listing was verified.

    Company research Official site

  • Assort Health

    Assort Health answers the practice phone with AI agents that book, move and cancel appointments and work incoming referrals, writing the result straight into the records system. The company says it works with more than 1,300 providers and resolves 95 percent of patient access calls without passing them to staff.

    No current public listing was verified.

    Company research Official site

What to verify: Whether the vendor can show you how patients actually arrive, including AI-mediated search, which is a different question from traditional SEO reporting.

Revenue Cycle and Administrative AI

Automation applied to coding, prior authorization, claims, and the administrative work that never touches a clinician.

  • AKASA

    AI for revenue cycle operations including coding and claim review, built specifically around health system billing rather than general document automation.

    No direct public shares are available.

    Company research Official site

  • CodaMetrix

    Autonomous medical coding company using clinical context and AI to code selected specialties and encounters inside health-system revenue-cycle work.

    No direct public shares are available.

    Company research Official site

  • Infinitus Systems

    Automates the payer phone call: benefit verification and prior authorization conversations that otherwise consume enormous staff time on hold.

    No direct public shares are available.

    Company research Official site

  • Candid Health

    Candid Health automates the insurance claim, from coding the visit to chasing the payer, so staff only touch the claims that actually need a person. The company says it works with more than 200 healthcare organisations, and it sells to medical groups rather than to hospital inpatient billing.

    No current public listing was verified.

    Company research Official site

What to verify: Whether the automation is measured against denial and rework rates, not just task volume. Faster wrong answers still cost money.

Drug Discovery and Life Sciences AI

AI applied upstream of care delivery: target identification, molecule design, and precision medicine data platforms.

  • Tempus

    Molecular data and precision medicine platform linking sequencing results to clinical records, used both at the point of oncology care and as a research data asset.

    Direct listing: Nasdaq: TEM.

    Company research Official site

  • Recursion

    Drug discovery built on high-throughput cellular imaging and machine learning to map biological relationships, running its own internal pipeline rather than only selling software.

    Direct listing: Nasdaq: RXRX.

    Company research Official site

  • Isomorphic Labs

    Alphabet spinout applying the protein structure prediction lineage of AlphaFold to drug design, working through pharmaceutical partnerships.

    Public parent: Alphabet, Nasdaq: GOOGL and GOOG.

    Company research Official site

  • Insilico Medicine

    Generative chemistry and target discovery platform, notable for advancing AI-originated candidates into clinical trials rather than stopping at preclinical claims.

    Direct listing: Hong Kong Stock Exchange: 03696.

    Company research Official site

  • BenevolentAI

    Knowledge-graph driven target identification, built on relationships extracted from biomedical literature and experimental data.

    No current public listing. Shares were delisted from Euronext Amsterdam on March 13, 2025.

    Company research Official site

  • Owkin

    AI drug discovery and biomedical research company. Its K Pro platform combines research tools with patient data to support scientific analysis and drug development.

    No current public listing was verified.

    Company research Official site

  • Iterative Health

    Iterative Health runs a network of community clinical trial sites and uses its own AI, called SKOUT, to read endoscopy and histology images and find patients who qualify for a study. Drug companies are the buyer, and gastroenterology and hepatology are its established areas, with cardiology and obesity being added.

    No current public listing was verified.

    Company research Official site

  • Chai Discovery

    Chai Discovery builds AI models that predict how molecules stick to each other and design new antibodies from scratch. It sells those models to drug companies rather than developing medicines itself, and Eli Lilly, Pfizer, Novartis, argenx and Bristol Myers Squibb have all signed up to use them.

    No current public listing was verified.

    Company research Official site

What to verify: How much of the pipeline is AI-originated versus AI-assisted, and what has actually reached a clinical endpoint rather than a press release.

Remote Monitoring and Virtual Care

Continuous monitoring and hospital-at-home platforms that move parts of care delivery outside the building.

  • Biofourmis

    Remote monitoring and care at home, combining patient data with clinical support. Biofourmis announced a merger with CopilotIQ to connect care across home-based services.

    No direct public shares are available.

    Company research Official site

  • Cadence

    Remote monitoring for chronic conditions such as hypertension and diabetes, operated as a managed service that includes the clinical staff acting on the readings.

    No direct public shares are available.

    Company research Official site

  • UpDoc

    UpDoc runs an AI system that manages a patient's insulin between visits, inside the treatment plan a physician has already written. The company says that system is FDA cleared, and in September 2026 a federal agency picked UpDoc to build a similar system for heart disease.

    No current public listing was verified.

    Company research Official site

What to verify: Who is responsible for acting on an alert at 3am, and whether the staffing model behind that answer actually exists.

Specialty Practice Platforms and AI

Compare platforms that bring patient records, appointments, billing, and AI tools together for specialty practices. Start with the work your practice needs to finish, then check which features are available today.

  • Nextech

    Connect visit notes, appointments, and billing in a specialty practice. Nextech combines records software with AI documentation and patient communication tools.

    No direct public listing for Nextech was verified.

    Company research Official site

What to verify: Does the platform fit the specialty's visit types and staff routines, and which AI functions can the practice use today?

Health Systems and Hospitals Using Healthcare AI

Hospitals and health systems that appear in this site's company news as the organizations buying healthcare AI, turning it on, and reporting what changed. These are care providers, not AI vendors. A record here exists because the organization played a named role in a sourced story.

  • ECU Health

    Not-for-profit health system in eastern North Carolina, built around an academic medical center in Greenville plus community hospitals in smaller towns. It appears in healthcare AI news as a health system whose own staff build AI agents inside its records system rather than waiting for a vendor to ship a feature.

    No current public listing was verified.

    Company research Official site

  • Ochsner Health

    Nonprofit health system across Louisiana, Mississippi and the Gulf South, and one of the largest academic medical centers in the country that is not run by a university. It appears in healthcare AI news as an early adopter that publishes its own numbers on patient outreach and new records system features.

    No current public listing was verified.

    Company research Official site

  • Ob Hospitalist Group

    Ob Hospitalist Group staffs hospital labor and delivery units with obstetric hospitalists who are present around the clock. Its own pages call it the nation's largest and only dedicated OB/GYN hospitalist provider, based in Greenville, South Carolina. It appears in healthcare AI news as a provider group that bought AI coding software and published what changed.

    No current public listing was verified.

    Company research Official site

  • Comprehensive Cancer Centers of Nevada

    Comprehensive Cancer Centers is a multi-specialty cancer practice in Southern Nevada covering medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, genetic counselling and clinical research. Its central business office is in Henderson, Nevada. It appears in healthcare AI news as an oncology practice that rolled ambient AI documentation out across its sites.

    No current public listing was verified.

    Company research Official site

What to verify: When a health system reports a result from an AI tool, who measured it, over how long, and would the same number hold at an organization with different staffing?

Drug and Biotech Partners in Healthcare AI

Drug and biotech companies that appear in this site's company news as research partners, trial sponsors, and licensees of healthcare AI. These companies pay for or partner on AI work rather than selling it. A record here exists because the company played a named role in a sourced story.

  • Endeavor BioMedicines

    Clinical-stage biotechnology company in San Diego developing medicines for diseases that scar organ tissue. Its lead program is taladegib, also called ENV-101, for idiopathic pulmonary fibrosis. It appears in healthcare AI news as the trial sponsor whose lung scans were measured by imaging AI.

    No current public listing was verified.

    Company research Official site

  • GSK

    GSK is a British drug and vaccine maker. Its own about page says it works in respiratory, immunology and inflammation, oncology, HIV and infectious diseases, with 58 medicines and vaccines in development. It shows up in healthcare AI news as a buyer of AI research tools rather than a seller of them.

    Direct listing: NYSE: GSK. The ordinary shares also trade in London, and the New York listing is an ADR programme.

    Company research Official site

  • Novartis

    Novartis is a Swiss drug maker. Its own about page says it works in cardiovascular, renal and metabolic disease, immunology, neuroscience and oncology, employs about 77,000 people, sells products in 118 countries and reached 304 million patients. In healthcare AI news it appears as a research partner and licensee, not as a company selling AI.

    Direct listing: NYSE: NVS. The shares also trade on the SIX Swiss Exchange under NOVN, and the New York listing is an ADR programme.

    Company research Official site

  • Sanofi

    Sanofi is a French drug and vaccine maker. Its own about page calls it a research and development driven, AI-powered biopharma company working across five areas: neurology, oncology, rare diseases, immunology and vaccines, with 61 compounds in clinical development and 20 trials in phase 3. In healthcare AI news it appears as a licensee of AI research tools rather than a seller of them.

    Direct listing: Nasdaq: SNY. The ordinary shares are listed on Euronext Paris, and the Nasdaq listing is an ADR programme.

    Company research Official site

What to verify: How far has the partnership actually gone: a lab evaluation, a signed licence, a trial that uses the AI measurement, or a medicine in a patient?

Ambient AI Scribe Software: How to Compare Vendors

Six companies dominate ambient clinical documentation and the marketing language is nearly identical across all of them. The questions that actually separate them are about correction time, retention, specialty fit, and coding behavior.

Read more

Ambient AI Scribes vs Traditional Medical Scribes

A human scribe and an ambient AI scribe produce a similar artifact through very different arrangements of cost, judgment, and accountability. The comparison that matters is not accuracy, it is what each one absorbs when the encounter gets complicated.

Read more

Healthcare AI Regulation: What Actually Governs It Right Now

There is no single 'AI in healthcare' law. What actually governs a healthcare AI tool today is a patchwork: FDA oversight if it qualifies as a medical device, HIPAA if it touches protected health information, ONC's HTI-1 transparency rule if it's in certified health IT, and voluntary frameworks like NIST's AI RMF filling the rest of the gap.

Read more

AI-Ready Healthcare Infrastructure

A hub for the healthcare AI infrastructure strategy layer: data locality, local inference, IBM Power 11, IBM i modernization, clinical governance, and hospital AI readiness.

Read more